Article info

Download PDFPDF
Letter
Use of single-dose tocilizumab for treatment of severe COVID-19 in pregnancy: implications for the timing of live infant vaccines

Authors

  1. Correspondence to Dr Ingrid Burkhardt, Children's Services, Imperial College Healthcare NHS Trust, London, W2 1NY, UK; burkhardt.ingrid{at}gmail.com
View Full Text

Citation

Burkhardt I, Whittaker E
Use of single-dose tocilizumab for treatment of severe COVID-19 in pregnancy: implications for the timing of live infant vaccines

Publication history

  • Accepted January 14, 2022
  • First published February 3, 2022.
Online issue publication 
September 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.